Menu

Enanta Pharmaceuticals, Inc. ENTA

Full chart Compare
Set alert

Price alert · ENTA

All alert types
11.00 USD +0.92 (+9.13%)

At closeNov 6, 2026, 4:01 PM EST

11.00 0.00 0.00%

After hours · Nov 6, 4:01 PM ET

10.07 Day range 11.13
10.08 52-week range 16.85
YTD
-30.25%
1 year
+1.85%

Revenue & Expenses

Other Income → Expenses: $9.48MIncome Tax Benefit → Expenses: $1.66MExpenses → Selling, General & Admin: $43.93MExpenses → Research & Development: $106.74MExpenses → Interest Expense: $7.68MGross Profit → Expenses: $65.32MRevenue → Gross Profit: $65.32MNet Loss → Expenses: $81.89MOther Income$9.48MIncome Tax Benefit$1.66MGross Profit$65.32MNet Loss$81.89MExpenses$158.35MSelling, General & Admin$43.93MResearch & Development$106.74MInterest Expense$7.68MRevenue$65.32M

Latest period ending Sep 30, 2025 · select a line to chart its full history

Annual income statement

ENTA annual income statement
Fiscal yearFY 2025 Sep 30, 2025FY 2024 Sep 30, 2024FY 2023 Sep 30, 2023FY 2022 Sep 30, 2022FY 2021 Sep 30, 2021
65.32M67.64M79.20M86.16M97.07M
65.32M67.64M79.20M86.16M97.07M
65.32M67.64M79.20M86.16M97.07M
150.67M189.33M216.41M210.00M206.65M
106.74M131.48M163.52M164.52M174.11M
43.93M57.85M52.89M45.48M32.54M
-85.35M-121.69M-137.21M-123.84M-109.57M
7.68M10.94M5.15M00
-1.66M-1.74M2.82M-433.00K-28.58M
-81.89M-116.05M-133.82M-121.75M-79.00M
-81.89M-116.05M-133.82M-121.75M-79.00M
-81.89M-116.05M-133.82M-121.75M-79.00M
-81.89M-116.05M-133.82M-121.75M-79.00M
-3.84-5.48-6.38-5.91-3.92
-3.84-5.48-6.38-5.91-3.92
-3.84-5.48-6.38-5.91-3.92
-75.87M-106.85M-125.85M-122.19M-107.58M
-75.87M-106.85M-125.85M-122.19M-107.58M
21.34M21.16M20.97M20.60M20.17M
21.34M21.16M20.97M20.60M20.17M